Literature DB >> 10333919

Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.

G E Reiber1, L Vileikyte, E J Boyko, M del Aguila, D G Smith, L A Lavery, A J Boulton.   

Abstract

OBJECTIVE: To determine the frequency and constellations of anatomic, pathophysiologic, and environmental factors involved in the development of incident diabetic foot ulcers in patients with diabetes and no history of foot ulcers from Manchester, U.K., and Seattle, Washington, research settings. RESEARCH DESIGN AND METHODS: The Rothman model of causation was applied to the diabetic foot ulcer condition. The presence of structural deformities, peripheral neuropathy, ischemia, infection, edema, and callus formation was determined for diabetic individuals with incident foot ulcers in Manchester and Seattle. Demographic, health, diabetes, and ulcer data were ascertained for each patient. A multidisciplinary group of foot specialists blinded to patient identity independently reviewed detailed abstracts to determine component and sufficient causes present and contributing to the development of each patient's foot ulcer. A modified Delphi process assisted the group in reaching consensus on component causes for each patient. Estimates of the proportion of ulcers that could be ascribed to each component cause were computed.
RESULTS: From among 92 study patients from Manchester and 56 from Seattle, 32 unique causal pathways were identified. A critical triad (neuropathy, minor foot trauma, foot deformity) was present in > 63% of patient's causal pathways to foot ulcers. The components edema and ischemia contributed to the development of 37 and 35% of foot ulcers, respectively. Callus formation was associated with ulcer development in 30% of the pathways. Two unitary causes of ulcer were identified, with trauma and edema accounting for 6 and < 1% of ulcers, respectively. The majority of the lesions were on the plantar toes, forefoot, and midfoot.
CONCLUSIONS: The most frequent component causes for lower-extremity ulcers were trauma, neuropathy, and deformity, which were present in a majority of patients. Clinicians are encouraged to use proven strategies to prevent and decrease the impact of modifiable conditions leading to foot ulcers in patients with diabetes.

Entities:  

Mesh:

Year:  1999        PMID: 10333919     DOI: 10.2337/diacare.22.1.157

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  195 in total

Review 1.  Diabetic foot disease in people with advanced nephropathy and those on renal dialysis.

Authors:  Agbor Ndip; Lawrence A Lavery; Andrew J M Boulton
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

Review 2.  Risk factors for diabetic neuropathy and foot ulceration.

Authors:  A Adler
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

3.  Modulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia.

Authors:  Lingdan Chen; Emmanuel Okeke; Dawit Ayalew; Danny Wang; Lyeba Shahid; Ayotunde O Dokun
Journal:  Exp Biol Med (Maywood)       Date:  2017-06-21

4.  Walking performance in people with diabetic neuropathy: benefits and threats.

Authors:  R V Kanade; R W M van Deursen; K Harding; P Price
Journal:  Diabetologia       Date:  2006-06-07       Impact factor: 10.122

Review 5.  Risk assessment of the diabetic foot and wound.

Authors:  Stephanie Wu; David G Armstrong
Journal:  Int Wound J       Date:  2005-03       Impact factor: 3.315

Review 6.  The epidemiology of neuropathic foot ulcers in individuals with diabetes.

Authors:  Jay Sosenko
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

7.  Characterisation of impaired wound healing in a preclinical model of induced diabetes using wide-field imaging and conventional immunohistochemistry assays.

Authors:  Mayer Saidian; Jonathan R T Lakey; Adrien Ponticorvo; Rebecca Rowland; Melissa Baldado; Joshua Williams; Maaikee Pronda; Michael Alexander; Antonio Flores; Li Shiri; Stellar Zhang; Bernard Choi; Roni Kohen; Bruce J Tromberg; Anthony J Durkin
Journal:  Int Wound J       Date:  2018-10-01       Impact factor: 3.315

8.  Pseudomonas aeruginosa uses T3SS to inhibit diabetic wound healing.

Authors:  Josef Goldufsky; Stephen J Wood; Vijayakumar Jayaraman; Omar Majdobeh; Lin Chen; Shanshan Qin; Chunxiang Zhang; Luisa A DiPietro; Sasha H Shafikhani
Journal:  Wound Repair Regen       Date:  2015-07-27       Impact factor: 3.617

Review 9.  Cellular and molecular basis of wound healing in diabetes.

Authors:  Harold Brem; Marjana Tomic-Canic
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

10.  Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study.

Authors:  David J Margolis; Jayanta Gupta; Stephen R Thom; Raymond R Townsend; Peter A Kanetsky; Ole Hoffstad; Maryte Papdopoulos; Michael Fischer; Jeffrey R Schelling; Nandita Mitra
Journal:  Wound Repair Regen       Date:  2012-12-10       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.